Freedland Cory S. has filed 4 insider transactions across 1 company since January 2024.
Most recent transaction: a grant/award of 12050 shares of Neurogene Inc. ($NGNE) on February 20, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 20, 2026 | Neurogene Inc. | $NGNE | Freedland Cory S. | Director | A | Non-Qualified Stock Option (right to buy) | 12050 | $0.00 | 12,050.0000 | 21,168,431 | 9999.99% | 0.06% |
| June 12, 2025 | Neurogene Inc. | $NGNE | Freedland Cory S. | Director | A | Non-Qualified Stock Option (right to buy) | 12050 | $0.00 | 12,050.0000 | 17,567,082 | 9999.99% | 0.07% |
| June 14, 2024 | Neurogene Inc. | $NGNE | Freedland Cory S. | Director | A | Stock Option (Right to Buy) | 7700 | $0.00 | 7,700.0000 | 4,656,947 | 9999.99% | 0.17% |
| Jan. 16, 2024 | Neurogene Inc. | $NGNE | Freedland Cory S. | Not found | A | Stock Option (Right to Buy) | 15400 | $0.00 | 15,400.0000 | 4,656,947 | 9999.99% | 0.33% |